How I treat HER2-low advanced breast cancer

INTRODUCTION: Targeting low levels of human receptor epidermal growth factor 2 (HER2) expression has reshaped the treatment paradigm for half of the patients with advanced breast cancer. HER2-low is currently defined as a HER2 immunohistochemical expression of 1+ or 2+ without amplification by in-si...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlam, Ilana, Tolaney, Sara M., Tarantino, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article(s) from the Special Issue on: Antibody-drug Conjugates; Edited by Giuseppe Curigliano, Hope Rugo
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982266/
https://www.ncbi.nlm.nih.gov/pubmed/36669993
http://dx.doi.org/10.1016/j.breast.2023.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982266/
https://www.ncbi.nlm.nih.gov/pubmed/36669993
http://dx.doi.org/10.1016/j.breast.2023.01.005

Ejemplares similares